2 unknown. 2 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Unknown 2 |
| Phase 2 | 2 | Unknown 2 |
Follow Corneal Disease: new trials by email Literature Review of Corneal Disease trials Research Report on Corneal Disease
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Investigate the Safety and Clinical Activity of Belantamab Mafodotin in Combination With Daratumumab, Lenalidomide and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Transplant Ineligible Belantamab Mafodotin-Blmf, Daratumumab, Lenalidomide - Multiple Myeloma, Neoplasms | Phase 1 / Phase 2 | Unknown | Hellenic Society of Hematology | 36 | 2022-04-13 | 2023-12-01 |
| Corneal Epithelium Repair and Therapy Using Autologous Limbal Stem Cell Transplantation LSCs and amniotic membrane (Modified Technique), Amniotic membrane only (Traditional Technique), PRK, LSCs, and amniotic membrane (Modified Technique) - Corneal Disease, Pterygium | Phase 1 / Phase 2 | Unknown | Sun Yat-sen University | 30 | 2012-12-01 | 2014-05-28 |
Corneal Diseases (2) · Blood Protein Disorders (1) · Hematologic Diseases (1) · Hyperopia (1) · Multiple Myeloma (1) · Myopia (1) · Neoplasms (1) · Neoplasms, Plasma Cell (1) · Paraproteinemias (1) · Pterygium (1) · Refractive Errors (1)
Eye Diseases (2) · Cardiovascular Diseases (1) · Conjunctival Diseases (1) · Hemic and Lymphatic Diseases (1) · Hemorrhagic Disorders (1) · Hemostatic Disorders (1) · Immune System Diseases (1) · Immunoproliferative Disorders (1) · Lymphoproliferative Disorders (1) · Neoplasms by Histologic Type (1) · Vascular Diseases (1)
Betamethasone (1) · Dexamethasone (1) · Lenalidomide (1) · Levofloxacin (1) · daratumumab (1)
Hellenic Society of Hematology (1) · Sun Yat-sen University (1)
China (1) · Greece (1)
Evangelos Terpos, Prof (1) · Yizhi Liu, MD, PhD (1)